Quantum Si

Quantum-Si is a biotechnology company based in Guilford, Connecticut, founded in 2013 by Dr. Jonathan Rothberg. The company focuses on developing advanced protein sequencing technology to enhance proteomics research and support drug discovery and diagnostics. Their main innovation is the Next-Gen Protein Sequencing™ (NGPS) platform, which utilizes a combination of biology, chemistry, artificial intelligence, and semiconductor technology. This platform allows for highly sensitive detection of single amino acids at the single-molecule level, enabling researchers to analyze proteins with exceptional precision. The flagship product, the Platinum™ instrument, was launched in 2022 and is designed to streamline protein sequencing workflows in research laboratories. Quantum-Si serves the proteomics and multiomics research communities, including pharmaceutical companies, biotechnology firms, and academic researchers. The company aims to provide deeper biological insights to facilitate breakthroughs in human health and disease treatment. With a commitment to making proteomics accessible, Quantum-Si continues to expand its product offerings and enhance its technology platform.